ECNP Taskforce on Nomenclature of Psychotropic Drugs
The ECNP Taskforce on Nomenclature of was established in 2010, driven by the need felt by ECNP and colleague colleges that the nomenclature of psychotropic drugs should be improved.
Changing the nomenclature of psychotropic drugs will have a great impact. It may, for example, increase compliance, as many patients show a reluctance to take certain medication because of the names presently given to medicines, like ‘anti-depressants'.
Therefore, next to the Colleges of Neuropsychopharmacology, the stakeholders for this project are not only regulatory bodies, physicians and pharmaceutical companies, but also patients, patient groups and relatives. It will be a complicated process and will also have implications for DSM-V.
The colleges ACNP, AsCNP, CINP and ECNP, assisted by the experienced chair of NC-IUPHAR, will be the best organisations to initiate the change. Reports to the field will be done through the college’s journals.
On this website, we aim to keep you updated on those reports.